{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:31:56Z","timestamp":1740130316019,"version":"3.37.3"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Statistical Analysis Plan"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,5]]},"DOI":"10.1093\/rheumatology\/keaa633","type":"journal-article","created":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T11:07:28Z","timestamp":1599995248000},"page":"e32-e33","source":"Crossref","is-referenced-by-count":1,"title":["Comment on: Equal rights in autoimmunity: is Sj\u00f6gren's syndrome ever \u2018secondary\u2019?"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1105-5640","authenticated-orcid":false,"given":"Alessia","family":"Alunno","sequence":"first","affiliation":[{"name":"Department of Medicine, Rheumatology Unit, University of Perugia, Perugia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4684-575X","authenticated-orcid":false,"given":"Roberto","family":"Gerli","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rheumatology Unit, University of Perugia, Perugia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4776-2136","authenticated-orcid":false,"given":"Elena","family":"Bartoloni","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rheumatology Unit, University of Perugia, Perugia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"key":"2021010517024682900_keaa633-B1","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/rheumatology\/keaa009","article-title":"Equal rights in autoimmunity: is Sj\u00f6gren\u2019s syndrome ever \u2018secondary\u2019?","volume":"59","author":"Kollert","year":"2020","journal-title":"Rheumatology"},{"key":"2021010517024682900_keaa633-B2","doi-asserted-by":"crossref","first-page":"540.","DOI":"10.3390\/jcm8040540","article-title":"Celiac disease prevalence is increased in primary Sj\u00f6gren's syndrome and diffuse systemic sclerosis: lessons from a large multi-center study","volume":"8","author":"Bartoloni","year":"2019","journal-title":"J Clin Med"},{"key":"2021010517024682900_keaa633-B3","first-page":"192","article-title":"The kaleidoscope of neurological manifestations in primary Sj\u00f6gren","volume":"37(Suppl 118)","author":"Alunno","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"2021010517024682900_keaa633-B4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/joim.12346","article-title":"Cardiovascular disease risk burden in primary Sj\u00f6gren's syndrome: results of a population-based multicentre cohort study","volume":"278","author":"Bartoloni","year":"2015","journal-title":"J Intern Med"},{"key":"2021010517024682900_keaa633-B5","article-title":"Performance of the 2016 ACR\/EULAR SS classification criteria in patients with secondary Sj\u00f6gren\u2019s syndrome","author":"Hern\u00e1ndez-Molina","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"2021010517024682900_keaa633-B6","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3899\/jrheum.090866","article-title":"Similarities and differences between primary and secondary Sj\u00f6gren\u2019s syndrome","volume":"37","author":"Hern\u00e1ndez-Molina","year":"2010","journal-title":"J Rheumatol"},{"key":"2021010517024682900_keaa633-B7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/14397595.2014.951144","article-title":"Efficacy and safety of abatacept for patients with Sj\u00f6gren's syndrome associated with rheumatoid arthritis: rheumatoid arthritis with orencia trial toward Sj\u00f6gren's syndrome Endocrinopathy (ROSE) trial\u2014an open-label, one-year, prospective study\u2014Interim analysis of 32 patients for 24 weeks","volume":"25","author":"Tsuboi","year":"2015","journal-title":"Mod Rheumatol"},{"key":"2021010517024682900_keaa633-B8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/s10165-004-0338-x","article-title":"Revised Japanese criteria for Sj\u00f6gren's syndrome (1999): availability and validity","volume":"14","author":"Fujibayashi","year":"2004","journal-title":"Mod Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/1\/e32\/35433623\/keaa633.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/1\/e32\/35433623\/keaa633.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T09:56:00Z","timestamp":1610272560000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/1\/e32\/5990283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,11,19]]},"published-print":{"date-parts":[[2021,1,5]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa633","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"type":"print","value":"1462-0324"},{"type":"electronic","value":"1462-0332"}],"subject":[],"published-other":{"date-parts":[[2021,1]]},"published":{"date-parts":[[2020,11,19]]}}}